Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Hongwei Lü

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8005-142X; OpenAlex author ID A5077339926. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. First author DOI 10.1016/j.jconrel.2023.11.028↗
  2. Case Report: A Pancreatic Ductal Adenocarcinoma Patient With Concurrent Targetable Somatic Novel KANK1-ALK, UPP2-NTRK3 Fusion, and Pathogenetic Germline BRCA M… Last author DOI 10.3389/fonc.2021.757965↗
  3. Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15. First author DOI 10.3892/mmr.2015.3867↗
  4. Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer. First author DOI 10.1371/journal.pone.0097239↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mingliang Liu · 1 shared paper, 2024 · strength 0.20
  2. Guimin Xia · 1 shared paper, 2024 · strength 0.20
  3. Dan Wang · 1 shared paper, 2024 · strength 0.20
  4. Xiaowei Wang · 1 shared paper, 2024 · strength 0.20
  5. Fan Meng · 1 shared paper, 2021 · strength 0.17
  6. Hong Long Ji · 2 shared papers, 2014–2015 · strength 0.10
  7. Hao Shang · 1 shared paper, 2015 · strength 0.06
  8. Tao Shan · 1 shared paper, 2014 · strength 0.05
  9. Tao Wu · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.